Monalisa Ghosh
Clinical Associate Professor of Internal Medicine
Medical School
Email:
[email protected]
Available to mentor
Monalisa Ghosh
Clinical Associate Professor
Manage Your Profile
Center Memberships
-
Center MemberRogel Cancer Center
Recent Publications
-
Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney MS, Ghosh M, Gergis U, Krueger A, Galinsky KJ, Bende G, Ramachandran A, Sundaresan V, Kasar S, Hupf B, Chen S, Sellner L, Karmali R. Blood Cancer Discovery, 2026 Apr 28;Journal ArticleA Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
DOI:10.1158/2643-3230.bcd-25-0323 -
Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney MS, Ghosh M, Gergis U, Krueger A, Galinsky KJ, Bende G, Ramachandran A, Sundaresan V, Kasar S, Hupf B, Chen S, Sellner L, Karmali R. Blood Cancer Discov, 2026 Apr 17;Journal ArticleA Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
DOI:10.1158/2643-3230.BCD-25-0323-A PMID: 41995697 -
Nunez D, Volkov JR, Little C, Ghosh M, Tsou P-S, Furmanak T, Dey P, Tsoi LC, Zahn C, Bogle R, Cai Y, Fox J, Stadanlick J, Werner M, Vorndran Z, Ishikawa L, Ellis A, Williams J, Cicarelli J, Flannagan S, Kobulsky D, Lam Q, Schmitt C, Nezhad F, Thompson D, Braccia D, Rivera TG, Tummala R, Gudjonsson JE, Ross C, Binder G, Chang D, Basu S, Khanna D. Mol Ther Adv, 2026 Mar 12; 34 (1): 201663Journal ArticleCase study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trial.
DOI:10.1016/j.omta.2025.201663 PMID: PMC13182784 -
Siebenaler R, Kiledal A, Geer MJ, Magenau J, Pawarode A, Anand S, Ghosh M, Maciejewski J, King D, Choi SW, Yanik GA, Reddy P, Riwes MM. Transplantation and Cellular Therapy, 2026 Feb 4; 32 (2): s247Proceeding / Abstract / PosterLongitudinal and Integrated Analysis of Oral and Stool Microbiome in Allogeneic Hematopoietic Cell Transplantation Recipients.
DOI:10.1016/j.jtct.2025.12.350 -
Siebenaler R, Magenau J, Pawarode A, Anand S, Ghosh M, Maciejewski J, Wong T, King D, Riwes MM, Frame D, Geer MJ. Transplantation and Cellular Therapy, 2026 Feb 4; 32 (2): s117Proceeding / Abstract / PosterMixed Chimerism Predicts Early Time to Relapse in Myeloablative Conditioning in Allogeneic Hematopoietic Stem Cell Transplant Patients
DOI:10.1016/j.jtct.2025.12.170 -
Raab G, Pawar A, Stahlbaum D, Srinivasan S, Capellini A, Magenau J, Riwes M, Anand S, Ghosh M, Geer M, Maciejewski, MD, PhD J, Pawarode A, Vander Lugt M, Abusin G, Read J, Triebwasser M, Choi S, Yanik GA. 2026 Jan 7;Proceeding / Abstract / PosterImpact of non-compliance with NIH Consensus Guidelines for PFT performance in allogeneic hematopoietic cell transplant recipients.
-
Siebenaler R, Kiledal EA, Geer M, Magenau J, Pawarode A, Anand S, Ghosh M, Maciejewski J, King D, Choi S, Yanik G, Reddy P, Riwes M. Blood, 2025 Dec 6; 146 (Supplement 1): 4225 - 4225.Proceeding / Abstract / PosterLongitudinal and integrated analysis of oral and stool microbiome in allogeneic hematopoietic cell transplantation recipients.
DOI:10.1182/blood-2025-4225 -
Maziarz RT, Bishop MR, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu J, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Ma W, Han X, Nuortti M, Awasthi R, Mundt KE, Majdan M, Maier HJ, Jegerlehner A, Salles G, Schuster SJ. J Clin Oncol, 2025 Nov 18; JCO2500507Journal ArticleFive-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.
DOI:10.1200/JCO-25-00507 PMID: 41252666
Featured News & Stories
News Release
The Mindset of an Athlete
Steve Burns, a former soccer coach, shares how he faced a 2024 relapse of large B-cell lymphoma in his brain, adapting to CNS lymphoma treatment one round at a time.
The Fundamentals
The Future of Cell and Gene Therapies
On this episode of The Fundamentals, we talked to physician scientist, Dr. Monalisa Ghosh, assistant professor of medical oncology and internal medicine, who is looking to expand CAR-T's application from cancer to autoimmune disorders and beyond.
Cancer Aware
CAR T-cell Therapy
Using one's cells to attack and treat cancer continues to grow. Cellular therapy and in particular CAR T-cell therapy offers new opportunities to adult and pediatric patients with blood cancers like leukemia and lymphoma. Dr. Monalisa Ghosh, Rogel Cancer Center oncologist talks about these treatments and and the future of cellular therapy.
Health Lab
Using cellular therapy to treat cancer, and beyond
Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.